JP2008512094A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512094A5
JP2008512094A5 JP2007530430A JP2007530430A JP2008512094A5 JP 2008512094 A5 JP2008512094 A5 JP 2008512094A5 JP 2007530430 A JP2007530430 A JP 2007530430A JP 2007530430 A JP2007530430 A JP 2007530430A JP 2008512094 A5 JP2008512094 A5 JP 2008512094A5
Authority
JP
Japan
Prior art keywords
fos
dusp1
protein
mrna
monocytes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512094A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/031469 external-priority patent/WO2006029052A2/en
Publication of JP2008512094A publication Critical patent/JP2008512094A/ja
Publication of JP2008512094A5 publication Critical patent/JP2008512094A5/ja
Pending legal-status Critical Current

Links

JP2007530430A 2004-09-03 2005-09-02 アテローム性動脈硬化症を評価する方法 Pending JP2008512094A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60703104P 2004-09-03 2004-09-03
US61827504P 2004-10-12 2004-10-12
PCT/US2005/031469 WO2006029052A2 (en) 2004-09-03 2005-09-02 Methods for assessing atherosclerosis

Publications (2)

Publication Number Publication Date
JP2008512094A JP2008512094A (ja) 2008-04-24
JP2008512094A5 true JP2008512094A5 (https=) 2008-09-04

Family

ID=36036914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007530430A Pending JP2008512094A (ja) 2004-09-03 2005-09-02 アテローム性動脈硬化症を評価する方法

Country Status (6)

Country Link
US (1) US7998682B2 (https=)
EP (1) EP1791977A2 (https=)
JP (1) JP2008512094A (https=)
AU (1) AU2005282636B2 (https=)
CA (1) CA2577819A1 (https=)
WO (1) WO2006029052A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010108092A2 (en) * 2009-03-19 2010-09-23 Phenotypeit, Inc. Medical health information system
JP5337096B2 (ja) 2010-04-28 2013-11-06 株式会社日立製作所 動脈硬化の評価法
US20190156923A1 (en) 2017-11-17 2019-05-23 LunaPBC Personal, omic, and phenotype data community aggregation platform
WO2020139379A1 (en) 2018-12-28 2020-07-02 LunaPBC Community data aggregation, completion, correction, and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2228235B1 (es) * 2002-12-17 2006-05-16 Consejo Sup. Investig. Cientificas Procedimiento de identificacion de nor-1 y/o nur77 y/o nurr1 para el diagnostico y seguimiento de enfermedades cardiovasculares.

Similar Documents

Publication Publication Date Title
Potter et al. Validation of a real-time PCR–based qualitative assay for the detection of methylated SEPT9 DNA in human plasma
Kearney et al. The building blocks of successful translation of proteomics to the clinic
JP2009523430A5 (https=)
CN109844532B (zh) 分析生物数据的系统和方法
CN109890977A (zh) 通过基于生物流体的无细胞dna(cfdna)测定评价器官损伤状态的基于免疫探针的新方法
JP2012525855A5 (https=)
CN101124340A (zh) 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定
JP2009506778A (ja) 生物学的状態の診断および／または治療に有用なバイオマーカを同定する方法および組成物
JP2012524883A (ja) 腎臓障害生物マーカとしてのｗｎｔ１
JP2016514966A (ja) 前立腺ガンの予後の検知及び判定のための組成物及び該検知及び判定方法
US8257917B2 (en) Salivary biomarkers for Sjögren's syndrome
RU2008115312A (ru) Способ диагностики печеночно-клеточной карциномы (пкк), способ оценки эффективности лечения, нуклеотидная последовательность, белок, антитело и ген для диагностики пкк, способ скрининга соединения для лечения пкк, способ диагностики начальной стадии пкк, нуклеотидная последовательность, белок, антитело и ген для диагностики начальной стадии пкк, способ крининга соединения для диагностики начальной стадии пкк, твердый носитель, набор и набор в качестве средства для диагностики пкк и начальной стадии пкк
WO2017040520A1 (en) Molecular methods for assessing urothelial disease
CN113444798A (zh) 肾癌生存风险生物标志物群及诊断产品和应用
IláKim Detection and quantification of the Bcr/Abl chimeric protein on biochips using LDI-TOF MS
Lim et al. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density
JP2008512094A5 (https=)
US20180274037A1 (en) Novel biomarkers for pancreatic diseases
Petrou et al. Lateral Flow Test (LFT) Detects Cell‐Free MicroRNAs Predictive of Preterm Birth Directly from Human Plasma
JP2023512701A5 (https=)
US20160244835A1 (en) Urinary neuropilin-1 (nrp-1) as a prognostic marker for nephritis and lupus nephritis
Thorsen et al. A targeted multiplex mass spectrometry method for quantitation of abundant matrix and cellular proteins in formalin-fixed paraffin embedded arterial tissue
Hansen et al. Finding diabetic nephropathy biomarkers in the plasma peptidome by high‐throughput magnetic bead processing and MALDI‐TOF‐MS analysis
KR101859812B1 (ko) 간암 화학 색전술 치료 예후 예측을 위한 바이오마커 및 그 용도
KR101832039B1 (ko) 간암 표적치료제 반응 예측용 바이오마커 및 그 용도